MM-MSC educated G-MDSCs demonstrate supportive effects in MM by upregulation of immune-suppressive and proangiogenic factors including arginase 1 (ARG1), tumor necrosis factor α (TNF-α), and prokineticin 2 (PROK2) [70]. The gene discussed is TNF; the disease is Miyoshi myopathy.